150 related articles for article (PubMed ID: 26857229)
1. Galectin-1 is a local but not systemic immunomodulatory factor in mesenchymal stromal cells.
Fajka-Boja R; Urbán VS; Szebeni GJ; Czibula Á; Blaskó A; Kriston-Pál É; Makra I; Hornung Á; Szabó E; Uher F; Than NG; Monostori É
Cytotherapy; 2016 Mar; 18(3):360-70. PubMed ID: 26857229
[TBL] [Abstract][Full Text] [Related]
2. Secreted galectin-3 as a possible biomarker for the immunomodulatory potential of human umbilical cord mesenchymal stromal cells.
Liu GY; Xu Y; Li Y; Wang LH; Liu YJ; Zhu D
Cytotherapy; 2013 Oct; 15(10):1208-17. PubMed ID: 23850421
[TBL] [Abstract][Full Text] [Related]
3. [Role of galectin-1 in regulation of umbilical cord mesenchymal stem cells on T cells of rheumatoid arthritis].
Sun L; An Z; Li CH; Liu R; Zhao JX; Liu XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):964-969. PubMed ID: 27987498
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1-induced skeletal muscle cell differentiation of mesenchymal stem cells seeded on an acellular dermal matrix improves injured anal sphincter.
Ding Z; Liu X; Ren X; Zhang Q; Zhang T; Qian Q; Liu W; Jiang C
Discov Med; 2016 May; 21(117):331-40. PubMed ID: 27355329
[TBL] [Abstract][Full Text] [Related]
5. Novel role for galectin-1 in T-cells under physiological and pathological conditions.
Deák M; Hornung Á; Novák J; Demydenko D; Szabó E; Czibula Á; Fajka-Boja R; Kriston-Pál É; Monostori É; Kovács L
Immunobiology; 2015 Apr; 220(4):483-9. PubMed ID: 25468561
[TBL] [Abstract][Full Text] [Related]
6. Identification of galectin-1 as a critical factor in function of mouse mesenchymal stromal cell-mediated tumor promotion.
Szebeni GJ; Kriston-Pál É; Blazsó P; Katona RL; Novák J; Szabó E; Czibula Á; Fajka-Boja R; Hegyi B; Uher F; Krenács L; Joó G; Monostori É
PLoS One; 2012; 7(7):e41372. PubMed ID: 22844466
[TBL] [Abstract][Full Text] [Related]
7. Bone Marrow Mesenchymal Stem Cells Inhibit the Function of Dendritic Cells by Secreting Galectin-1.
Zhang Y; Ge XH; Guo XJ; Guan SB; Li XM; Gu W; Xu WG
Biomed Res Int; 2017; 2017():3248605. PubMed ID: 28713822
[TBL] [Abstract][Full Text] [Related]
8. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
9. Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells.
Perone MJ; Larregina AT; Shufesky WJ; Papworth GD; Sullivan ML; Zahorchak AF; Stolz DB; Baum LG; Watkins SC; Thomson AW; Morelli AE
J Immunol; 2006 Jun; 176(12):7207-20. PubMed ID: 16751364
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory stimuli induce galectin-9 in human mesenchymal stromal cells to suppress T-cell proliferation.
Gieseke F; Kruchen A; Tzaribachev N; Bentzien F; Dominici M; Müller I
Eur J Immunol; 2013 Oct; 43(10):2741-9. PubMed ID: 23817958
[TBL] [Abstract][Full Text] [Related]
11. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes.
Najar M; Raicevic G; Jebbawi F; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Immunol Lett; 2012 Aug; 146(1-2):50-6. PubMed ID: 22575528
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive capabilities of mesenchymal stromal cells are maintained under hypoxic growth conditions and after gamma irradiation.
Nold P; Hackstein H; Riedlinger T; Kasper C; Neumann A; Mernberger M; Fölsch C; Schmitt J; Fuchs-Winkelmann S; Barckhausen C; Killer M; Neubauer A; Brendel C
Cytotherapy; 2015 Feb; 17(2):152-62. PubMed ID: 25453724
[TBL] [Abstract][Full Text] [Related]
13. Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions.
Najar M; Raicevic G; Id Boufker H; Stamatopoulos B; De Bruyn C; Meuleman N; Bron D; Toungouz M; Lagneaux L
Exp Hematol; 2010 Oct; 38(10):922-32. PubMed ID: 20570633
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
15. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
[TBL] [Abstract][Full Text] [Related]
16. Human mesenchymal stromal cells modulate T-cell immune response via transcriptomic regulation.
Vellasamy S; Tong CK; Azhar NA; Kodiappan R; Chan SC; Veerakumarasivam A; Ramasamy R
Cytotherapy; 2016 Oct; 18(10):1270-83. PubMed ID: 27543068
[TBL] [Abstract][Full Text] [Related]
17. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model.
Jia Z; Jiao C; Zhao S; Li X; Ren X; Zhang L; Han ZC; Zhang X
Exp Eye Res; 2012 Sep; 102():44-9. PubMed ID: 22800963
[TBL] [Abstract][Full Text] [Related]
19. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
